Latest Healthcare Research Reports

Tag: breath biopsy testing market analysis

  • Breath Biopsy Testing Market Growth Outlook Reveals A CAGR Of 7.3% And A Market Value Of $4.89 Billion By 2030

    Breath Biopsy Testing Market Growth Outlook Reveals A CAGR Of 7.3% And A Market Value Of $4.89 Billion By 2030

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    Breath Biopsy Testing Market Expected To Reach $4.89 Billion By 2030 At 7.3% CAGR

    The global market for breath biopsy testing has experienced robust expansion, projecting a rise from $3.43 billion in 2025 to $3.69 billion in 2026, signifying a compound annual growth rate of 7.7%. This historical growth trajectory is underpinned by several key factors, including a heightened demand for non-invasive diagnostic methods, expanded clinical investigations into breath biomarkers, significant technological progress in sensor and spectroscopy applications, the burgeoning growth of diagnostic laboratory services, and an increasing patient inclination towards painless medical examinations.

    The market for breath biopsy testing is projected for substantial expansion in the upcoming years, reaching an estimated value of $4.9 billion by 2030 with a compound annual growth rate (CAGR) of 7.3%. This projected growth is propelled by several key factors, including a greater acceptance of breath analysis for standard health screenings, increased financial backing for diagnostic tools powered by artificial intelligence, the broadening scope of personalized medicine, the increasing prevalence of portable diagnostic equipment, and enhanced regulatory endorsement for less invasive diagnostic procedures. During this forecast period, significant market trends are expected to emerge, such as a heightened preference for non-invasive diagnostic methods, a rise in the utilization of volatile organic compound (VOC) detection for identifying diseases, the growing integration of AI in analyzing breath samples, the expansion of handheld breath sampling apparatus, and an intensified emphasis on the early detection of illnesses.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    #Breath Biopsy Testing Market Growth Factors: Which Forces Are Supporting Market Expansion?

    An increasing incidence of respiratory ailments is anticipated to fuel the expansion of the breath biopsy testing sector. These respiratory conditions affect the lungs and breathing passages, impeding effective respiration. Factors contributing to the heightened occurrence of such diseases include escalating environmental pollution, elevated smoking rates, and the growing presence of chronic illnesses like asthma and COPD. Breath biopsy tests are instrumental in diagnosing respiratory diseases by presenting a less invasive, swift, and potentially superior approach to identifying disease-related biomarkers, thereby enhancing early detection and therapeutic strategies. For illustration, data from May 2025 by the Centers for Disease Control and Prevention (CDC) indicate that COPD was the fifth leading cause of mortality in the United States in 2023, with 141,733 fatalities, and the age-adjusted prevalence of diagnosed COPD among adults stood at 3.8% during that same year. Consequently, the escalating rate of respiratory illnesses is poised to be a significant driver for the breath biopsy testing market.

    Breath Biopsy Testing Market Segmentation Trends And Revenue Drivers

    The breath biopsy testing market covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Breath Biopsy Testing Market Industry Trends: What Changes Are Reshaping Demand?

    In the competitive landscape of the breath biopsy testing sector, leading firms are concentrating on pioneering breath analysis devices aimed at diagnosing conditions like asthma. These analyzers function by identifying and quantifying particular substances present in exhaled air, thereby aiding in the diagnosis of illnesses or the evaluation of overall well-being. As an illustration, in May of 2023, GenWorks, a healthcare solutions company headquartered in India, introduced the FenomPro breath analyzer. This particular device distinguishes itself through its swift FeNO testing functionality, producing outcomes in a mere 28 seconds. Engineered for simplicity in clinical environments, it delivers precise evaluations essential for the diagnosis, screening, and ongoing management of asthma. The FenomPro further boasts a rechargeable battery for enhanced mobility, incorporates an intuitive interface, and effectively ascertains the necessity for treatment or the prescription of inhalers for patients.

    #Breath Biopsy Testing Market Industry Leaders: Which Organizations Are Driving Competition?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    Access The Complete Breath Biopsy Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Breath Biopsy Testing Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the breath biopsy testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Breath Biopsy Testing Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    Breath Biopsy Testing Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Market Size Is Forecasted For The Breath Biopsy Testing Market By 2030 Based On Its 2026 Value?

    The bronchitis treatment market has experienced robust expansion in recent years. It is anticipated to increase from $5.92 billion in 2025 to $6.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.5%. The historical growth can be ascribed to elements such as the growing occurrence of respiratory infections, historically rising smoking rates, exposure to urban air pollution, the widespread adoption of bronchodilators and antibiotics, and established hospital-based respiratory care models.

    The bronchitis treatment market is projected to experience robust expansion over the coming years. This market is set to reach a valuation of $8.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period stems from factors such as a heightened emphasis on preventive respiratory care, the increasing uptake of digital inhalers, the broader availability of telehealth services for respiratory conditions, an expanding senior demographic, and improved understanding of how to manage chronic respiratory diseases. Key developments expected during this period involve a greater reliance on combination drug regimens, a surge in the use of inhalation-based therapies, an intensified focus on strategies for symptom management, the proliferation of home-based respiratory care options, and more sophisticated monitoring for individuals with chronic bronchitis.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    Which Strategic Drivers Are Supporting The Breath Biopsy Testing Market Development?

    The anticipated rise in respiratory disease cases is projected to drive the expansion of the bronchitis treatment market in the future. Respiratory illnesses are defined as conditions impacting the lungs and other components of the respiratory system. These conditions may target either the upper or lower respiratory tract and stem from various elements such as infections, allergens, irritants, and inherited susceptibilities. The approach to bronchitis treatment for respiratory diseases varies based on the underlying cause and the severity of the ailment. Common bronchitis treatments encompass antibiotics, anti-inflammatory medications, and bronchodilators designed to open the airways within respiratory organs. For example, data from June 2025 by Public Health Wales and National Health Service Wales, a U.K.-based national public health agency, indicated that in 2023/24, around 237,400 individuals were diagnosed with asthma and 75,600 with chronic obstructive pulmonary disease (COPD). Projections suggest these figures will increase to approximately 256,400 asthma cases and 84,800 COPD cases by 2033/34, underscoring a consistent increase in the prevalence of respiratory diseases. Consequently, the rising occurrence of respiratory illnesses is fueling the expansion of the bronchitis treatment market moving forward.

    What Key Segment Areas Are Included In The Breath Biopsy Testing Market Assessment?

    The breath biopsy testing market covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Which Trends Are Affecting The Breath Biopsy Testing Market Framework?

    Leading companies in the bronchitis treatment market are innovating technologies such as dry powder inhalers (DPI) to heighten drug delivery precision, optimize dosing, and elevate the overall patient experience by making bronchitis treatment more accessible and user-friendly for individuals. Dry Powder Inhalers (DPI) function as devices that dispense medication in a dry powder form directly into the lungs, thereby enabling effective therapy for respiratory conditions. For example, in November 2023, Lupin Limited, an India-based pharmaceutical company, unveiled Vilfuro-G. Vilfuro-G incorporates three active components, namely vilanterol, fluticasone furoate, and glycopyrronium bromide, within a single inhaler. This specific blend is formulated to deliver holistic management of COPD symptoms, simultaneously addressing inflammation, bronchoconstriction, and mucus production.

    Which Companies Are Engaged In The Breath Biopsy Testing Market Environment?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    Access The Complete Breath Biopsy Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Which Area Represents The Largest Portion Of The Breath Biopsy Testing Market?

    North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Breath Biopsy Testing Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

    Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

    Biopsy Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Liquid Biopsy For Cancer Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

    Smart Biopsy Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Breath biopsy testing market outlook (2026–2030) with growth drivers

    Breath biopsy testing market outlook (2026–2030) with growth drivers

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Breath Biopsy Testing Market Expected To Scale Between 2026 And 2030?

    The breath biopsy testing market size has seen strong expansion in recent years. It is anticipated to grow from $3.43 billion in 2025 to $3.69 billion in 2026, registering a compound annual growth rate (CAGR) of 7.7%. The market’s growth during the historical period can be attributed to factors such as increased demand for non-invasive diagnostics, the advancement of clinical research on breath biomarkers, innovations in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a rising patient preference for painless testing methods.

    The breath biopsy testing market is anticipated to experience substantial expansion over the coming years. Projections indicate it will reach a valuation of $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected increase is largely due to factors such as the greater acceptance of breath-based diagnostic methods in standard health screenings, heightened investments in AI-powered diagnostic platforms, the broadening scope of personalized medicine uses, the increasing deployment of portable diagnostic tools, and improved regulatory backing for non-invasive testing. Key developments expected during this period involve a rise in the adoption of non-invasive diagnostic approaches, growing utilization of VOC-based disease identification, enhanced incorporation of AI-driven breath analysis, the proliferation of portable breath sampling devices, and a stronger emphasis on early disease detection.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    What Key Factors Are Affecting The Breath Biopsy Testing Market Demand?

    An increase in respiratory illnesses is anticipated to boost the expansion of the breath biopsy testing market in the future. These conditions are defined as health issues affecting the lungs and air passages, which impair effective breathing. The widespread occurrence of respiratory diseases stems from factors like escalating environmental pollution, elevated smoking rates, and the rising incidence of long-term ailments such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is necessary for respiratory diseases because it provides a non-invasive, quick, and potentially more precise approach for identifying biomarkers linked to these ailments, thereby enhancing early detection and treatment. For example, data from May 2025, provided by the Centers for Disease Control and Prevention (CDC), a U.S. government public health organization, indicated that chronic obstructive pulmonary disease (COPD) was the fifth primary cause of mortality in the United States in 2023, responsible for 141,733 deaths. In the same year, the age-adjusted rate of diagnosed COPD among adult individuals reached 3.8%. Consequently, the increasing occurrence of respiratory conditions will fuel the expansion of the breath biopsy testing market.

    What Are The Different Segment Types In The Breath Biopsy Testing Market Segment Breakdown?

    The breath biopsy testing market covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    What Trends Are Influencing Changes In The Breath Biopsy Testing Market?

    Leading companies in the breath biopsy testing market are concentrating on developing advanced products, such as breath analyzers, for asthma detection. These diagnostic tools are designed to identify and quantify specific compounds in a person’s breath to pinpoint medical conditions or gauge health status. Illustratively, in May 2023, GenWorks, an India-based healthcare solutions provider, introduced the FenomPro breath analyzer. A key feature of the FenomPro breath analyzer is its rapid FeNO testing capability, which yields results in merely 28 seconds. Developed for easy operation in clinical settings, it delivers accurate assessments for diagnosing, screening, and monitoring asthma. The instrument also incorporates a rechargeable battery for portability, presents a user-friendly interface, and effectively helps determine if patients require treatment or inhaler prescriptions.

    Who Are The Well-Known Companies In The Breath Biopsy Testing Market?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    Get The Full Breath Biopsy Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Which Region Leads The Breath Biopsy Testing Market In Overall Market Size?

    North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Breath Biopsy Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

    Smart Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Liquid Biopsy For Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Breath Biopsy Testing Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    Breath Biopsy Testing Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Large Is The Breath Biopsy Testing Market Projected To Become By 2030 Based On Its 2026 Valuation?

    The breath biopsy testing market size has experienced substantial growth in recent years. It is anticipated to expand from $3.43 billion in 2025 to $3.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. The historical growth in this sector is largely due to factors such as an increasing need for non-invasive diagnostics, the broadening of clinical research focused on breath biomarkers, significant advancements in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a growing patient preference for painless testing methods.

    The breath biopsy testing market is projected to experience robust expansion in the coming years, with its size anticipated to reach $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is largely driven by factors such as the increasing adoption of breath-based diagnostics in routine screening, a rise in investments towards AI-enabled diagnostic platforms, the expansion of personalized medicine applications, the growing utilization of portable diagnostic devices, and stronger regulatory support for non-invasive testing. Prominent trends throughout this period will encompass the increasing embrace of non-invasive diagnostic techniques, a rising application of VOC-based disease detection, the deepening integration of AI-driven breath analysis, the broader deployment of portable breath sampling devices, and an intensified focus on early disease screening.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    What Primary Drivers Are Shaping The Development Of The Breath Biopsy Testing Market?

    The growing incidence of respiratory ailments is poised to fuel the expansion of the breath biopsy testing market. These are medical conditions affecting the lungs and airways, thereby impeding efficient respiration. Factors contributing to their widespread occurrence include escalating environmental pollution, elevated smoking rates, and the increasing presence of chronic illnesses such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is crucial for respiratory diseases as it provides a non-invasive, rapid, and potentially more accurate approach for identifying biomarkers linked to these conditions, thereby enhancing early detection and management. For instance, as reported in May 2025 by the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, chronic obstructive pulmonary disease (COPD) stood as the fifth leading cause of mortality in the United States in 2023, resulting in 141,733 deaths. Furthermore, during the same year, the age-adjusted prevalence of diagnosed COPD among adults reached 3.8%. Consequently, the increasing occurrence of respiratory diseases is expected to stimulate the growth of the breath biopsy testing market.

    What Segment Groups Are Identified Within The Breath Biopsy Testing Market?

    The breath biopsy testing market covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Which Trends Are Influencing The Breath Biopsy Testing Market?

    Leading companies in the breath biopsy testing market are concentrating on developing innovative products, such as breath analyzers, for detecting asthma. Breath analyzers are diagnostic tools designed to identify and measure specific compounds in a person’s breath to pinpoint medical conditions or gauge health status. For example, in May 2023, GenWorks, an India-based healthcare solutions provider, introduced the FenomPro breath analyzer. The FenomPro breath analyzer stands out with its rapid FeNO testing capability, yielding results in just 28 seconds. Created for simple operation in clinical settings, it delivers accurate assessments for diagnosing, screening, and monitoring asthma. The device features a rechargeable battery for portability, an easy-to-use interface, and effectively determines if patients require treatment or inhaler prescriptions.

    Which Companies Hold Significant Positions In The Breath Biopsy Testing Market?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    Read the full breath biopsy testing market report here:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    How Does The Breath Biopsy Testing Market Perform Across Major Global Regions?

    North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Breath Biopsy Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

    Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

    Biopsy Devices Global Market Report

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Liquid Biopsy For Cancer Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

    Smart Biopsy Devices Global Market Report

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Breath Biopsy Testing Sector Forecast Shows Robust Momentum, Climbing to $4.89 Billion With 7.3% CAGR

    Breath Biopsy Testing Sector Forecast Shows Robust Momentum, Climbing to $4.89 Billion With 7.3% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the breath biopsy testing market from 2026–2035 with trusted insights from The Business Research Company

    What are the forecasted starting (2026) and ending (2030) market sizes for the Breath Biopsy Testing Market?

    The breath biopsy testing market has experienced substantial expansion over the past few years. Projections indicate its value will increase from $3.43 billion in 2025 to $3.69 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. This historical growth is primarily driven by factors such as a heightened demand for non-invasive diagnostic methods, increased clinical research focused on breath biomarkers, progress in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a growing patient inclination towards painless testing procedures.

    The breath biopsy testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing integration of breath-based diagnostics into standard screening procedures, a rise in investments directed towards AI-enabled diagnostic platforms, the broadening scope of personalized medicine applications, the expanding utilization of portable diagnostic tools, and enhanced regulatory backing for non-invasive testing methods. Key trends anticipated within the forecast timeframe encompass the wider acceptance of non-invasive diagnostic approaches, a growing reliance on VOC-based methods for disease identification, the progressive integration of AI-powered breath analysis, the proliferation of portable devices for breath sampling, and a heightened emphasis on early disease screening initiatives.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    What Drivers Are Supporting Technological Adoption In The Breath Biopsy Testing Market?

    The growing prevalence of respiratory diseases is projected to drive the expansion of the breath biopsy testing market moving forward. Respiratory diseases are medical conditions that affect the lungs and airways, hindering an individual’s ability to breathe properly. The increased occurrence of these conditions is attributed to factors such as rising environmental pollution, higher rates of smoking, and the increasing incidence of chronic illnesses like asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing becomes essential for respiratory diseases by offering a non-invasive, rapid, and potentially more accurate method for identifying biomarkers associated with these conditions, thus improving early diagnosis and management. For instance, in May 2025, the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, indicated that chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States in 2023, accounting for 141,733 deaths. During that same year, the age-adjusted prevalence of diagnosed COPD among adults reached 3.8%. Therefore, the increasing prevalence of respiratory diseases will stimulate the growth of the breath biopsy testing market.

    Which Segments Are Contributing To The Growth Of The Breath Biopsy Testing Market?

    The breath biopsy testing market covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Which Trends Are Influencing The Performance And Direction Of The Breath Biopsy Testing Market?

    Key companies active in the breath biopsy testing market are prioritizing the creation of novel products, such as breath analyzers, aimed at detecting asthma. Breath analyzers serve as diagnostic instruments that identify and quantify specific compounds within an individual’s breath to pinpoint medical conditions or gauge health status. Illustratively, in May 2023, GenWorks, an India-based healthcare solutions provider, unveiled the FenomPro breath analyzer. The FenomPro breath analyzer stands out for its rapid FeNO testing capability, yielding results in just 28 seconds. Engineered for straightforward use in clinical environments, it delivers precise assessments for the diagnosis, screening, and tracking of asthma. This device incorporates a rechargeable battery for ease of transport, features an intuitive user interface, and effectively ascertains whether patients require treatment or inhaler prescriptions.

    Who Are The Major Companies Operating In The Breath Biopsy Testing Market?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Breath Biopsy Testing Market?

    North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Breath Biopsy Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

    Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

    Smart Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Liquid Biopsy For Cancer Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Breath Biopsy Testing Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

    Breath Biopsy Testing Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

    Discover trends, market shifts, and competitive outlooks for the breath biopsy testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    How Has The Breath Biopsy Testing Market Size Shifted, And What Is the Outlook Through 2034?

    There has been substantial growth in the breath biopsy testing market in the previous years. The market size is anticipated to expand from $3.18 billion in 2024 to $3.43 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The significant growth in the historic period can be credited to favorable government initiatives, a transition towards non-invasive diagnostics, enhanced consumer consciousness about preventive health measures, increased usage in cancer research, and rising application in the treatment of metabolic disorders.

    In the coming years, the breath biopsy testing market is anticipated to experience robust growth. By 2029, it is projected that this market will reach a value of $4.57 billion, with a compound annual growth rate (CAGR) of 7.5%. The significant growth expected in this timeframe can be accredited to an increase in respiratory diseases, heightened awareness for early disease diagnosis, the broadening of clinical research and trials, a rising elderly population, and an increased prevalence of infectious diseases. Key trends projected in the forecast period include advancements in breath analysis technology, the demand for tailored medicine, enhancements in healthcare infrastructure, partnerships between diagnostic organisations and hospitals, and the utilization of artificial intelligence and data analytics.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    What Are the Core Market Drivers Propelling Growth in the Breath Biopsy Testing Industry?

    The escalating occurrence of respiratory illnesses is projected to fuel the advancement of the breath biopsy testing market. These diseases negatively affect the airways and lungs, impairing efficient breathing. They are primarily a result of increased environmental pollution, escalating smoking rates, and the escalating occurrence of chronic conditions such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is necessary for these respiratory issues as it offers a non-invasive, fast, and potentially more precise way to identify biomarkers related to these conditions – improving early diagnosis and treatment. For instance, a report issued by the Centers for Disease Control and Prevention, a US government agency, in November 2023, revealed that the United States reported approximately 8,331 tuberculosis cases in 2022, signifying a 5.9% rise from 2021. The incidence rate escalated to 2.5 cases per 100,000 people, showing a 5.5% increase from the prior year. Consequently, the escalating occurrence of respiratory illnesses will spur the growth of the breath biopsy testing market.

    How Is the Breath Biopsy Testing Market Segmented?

    The breath biopsy testingmarket covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

    Which Regions Are Driving the Next Phase of the Breath Biopsy Testing Market Growth?

    North America was the largest region in the breath biopsy testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Key Market Trends and Innovations Are Shaping the Future of the Breath Biopsy Testing Industry?

    Prominent firms in the breath biopsy testing market are honing in on the introduction of novel products, such as breath analyzers, for asthma detection. These diagnostic tools identify and quantify particular compounds in one’s breath to determine health conditions or health status. For example, in May 2023, healthcare solutions provider GenWorks, based in India, introduced the FenomPro breath analyzer. In particular, the FenomPro breath analyzer stands out due to its fast FeNO testing feature, delivering results in a mere 28 seconds. Crafted for easy application in clinical environments, it delivers precise evaluations for the diagnosis, screening, and monitoring of asthma. The apparatus comes with a rechargeable battery for mobility, boasts a user-friendly interface, and adeptly identifies if patients necessitate treatment or prescriptions for inhalers.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    How Is the Breath Biopsy Testing Market Defined and What Are Its Core Parameters?

    Breath biopsy testing is a non-invasive diagnostic method that analyzes the chemical compounds in a person’s breath to detect and diagnose diseases. This testing is based on the principle that certain diseases, metabolic conditions, and physiological states produce unique chemical markers or volatile organic compounds (VOCs) that can be detected in the exhaled breath.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19351

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Future Outlook of the Breath Biopsy Testing Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Breath Biopsy Testing Market: Growth, Trends, and Emerging Opportunities Explored

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the breath biopsy testing market grown in recent years?

    The breath biopsy testing market has expanded significantly, with growth projected from $3.18 billion in 2024 to $3.43 billion in 2025 at a CAGR of 7.8%. Past growth has been fueled by supportive government initiatives, a shift toward non-invasive diagnostics, greater consumer awareness of preventive healthcare, increased applications in oncology research, and growing use in metabolic disorder detection.

    How is the breath biopsy testing market size expected to evolve during the forecast period?

    The breath biopsy testing market is projected to experience strong growth, reaching $4.57 billion by 2029 at a CAGR of 7.5%. Growth drivers include rising cases of respiratory diseases, greater awareness of early disease detection, expanded clinical research and trials, an aging population, and the increasing prevalence of infectious diseases. Noteworthy trends in this sector involve advancements in breath analysis technology, a growing demand for personalized medicine, significant investments in healthcare infrastructure, partnerships between diagnostic firms and hospitals, and the integration of AI and data analytics.

    Get your breath biopsy testing market report here!

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Which key drivers are propelling the breath biopsy testing market’s growth?

    The growing prevalence of respiratory diseases is accelerating the breath biopsy testing market. Respiratory diseases, which affect lung and airway function, are increasing due to environmental pollution, smoking, and chronic conditions like asthma and COPD. Breath biopsy testing provides a non-invasive and efficient method for detecting biomarkers, aiding early diagnosis and management. For instance, the Centers for Disease Control and Prevention reported in November 2023 that tuberculosis cases in the U.S. rose by 5.9% in 2022, reaching 8,331, with an incidence rate of 2.5 cases per 100,000 people. Therefore, the growing prevalence of respiratory diseases is driving the breath biopsy testing market.

    What are the market segments in the breath biopsy testing industry?

    The breath biopsy testingmarket covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    Which leading companies are shaping the growth of the breath biopsy testing market?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc., Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    What key trends are currently impacting the breath biopsy testing market’s development?

    Top firms in the breath biopsy testing market are concentrating on creating innovative items, like breath analyzers, for detecting asthma. Breath analyzers serve as diagnostic tools that identify and calculate certain compounds in a person’s breath to detect health conditions or evaluate general health. For example, GenWorks, a healthcare solutions enterprise based in India, unveiled the FenomPro breath analyzer in May 2023. The FenomPro breath analyzer boasts a unique attribute with its speedy FeNO testing feature, producing findings in just 28 seconds. Built for convenient use in medical environments, it delivers precise evaluations for diagnosing, screening, and tracking asthma. The apparatus comes with a rechargeable battery for mobility, boasts a user-friendly interface, and effectively gauges if patients require treatment or prescriptions for inhalers.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19351

    Which geographic areas are influencing the growth of the breath biopsy testing market?

    North America was the largest region in the breath biopsy testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Smart Biopsy Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Non-invasive Prenatal Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Pharma Microbiology Testing Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis of the Breath Biopsy Testing Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Comprehensive Analysis of the Breath Biopsy Testing Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Projected Compound Annual Growth Rate (CAGR) of the Breath Biopsy Testing Market from 2025 to 2034, and What Factors Influence It?

    In recent times, the market size for breath biopsy testing has seen robust growth. The market, which is expected to expand from $3.18 billion in 2024 to $3.43 billion in 2025, is projected to grow at a compound annual growth rate (CAGR) of 7.8%. Factors such as government support programs, an increasing preference for non-invasive diagnostic methods, heightened consumer awareness about preventive healthcare, its rising usage in oncology research, and its growing application in the treatment of metabolic disorders have contributed to the growth observed in the historical period.

    It is anticipated that the size of the breath biopsy testing market will be experiencing significant expansion over the next few years. Its growth is projected to reach $4.57 billion by 2029 with a compound annual growth rate (CAGR) of 7.5%. The upswing during the prediction period can be traced back to a rising occurrence of respiratory ailments, increased cognizance of detecting diseases early, widening of clinical research and trials, growing elderly population and an increase in the pervasiveness of infectious diseases. Noteworthy trends in the prediction span include advances in breath examination technology, a surge in demand for tailored medicine, investment in medical infrastructure, partnerships between diagnostic firms and hospitals, as well as the adoption of artificial intelligence and data analytics.

    What Combination of Drivers Is Leading to Accelerated Growth in the Breath Biopsy Testing Market?

    The escalating incidence of respiratory illnesses is anticipated to fuel the expansion of the breath biopsy testing market. Respiratory disorders encompass health issues that impair a person’s lung and airway function, inhibiting their capacity to breathe effectively. The rise in these diseases is largely due to escalating environmental pollution, increased smoking rates, and the growing incidence of chronic disorders such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is necessary for these respiratory conditions as it provides a non-invasive, swift, and potentially more precise technique for identifying biomarkers associated with these issues, hence enhancing early diagnosis and treatment. For example, a report by the Centers for Disease Control and Prevention, a US government agency, revealed in November 2023 that the United States recorded about 8,331 tuberculosis cases in 2022, indicating a 5.9% growth from 2021. The incidence rate mounted to 2.5 cases per 100,000 people, indicating a 5.5% increase compared to the prior year. Hence, the escalating incidence of respiratory diseases is expected to boost the growth of the breath biopsy testing market.

    Explore Comprehensive Insights Into The Global Breath Biopsy Testing Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    Who Are the Leading Players Fueling Growth in the Breath Biopsy Testing Market?

    Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc., Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

    What Are the Emerging Trends Shaping the Future of the Breath Biopsy Testing Market?

    Top firms in the breath biopsy testing market are concentrating on creating innovative items, like breath analyzers, for detecting asthma. Breath analyzers serve as diagnostic tools that identify and calculate certain compounds in a person’s breath to detect health conditions or evaluate general health. For example, GenWorks, a healthcare solutions enterprise based in India, unveiled the FenomPro breath analyzer in May 2023. The FenomPro breath analyzer boasts a unique attribute with its speedy FeNO testing feature, producing findings in just 28 seconds. Built for convenient use in medical environments, it delivers precise evaluations for diagnosing, screening, and tracking asthma. The apparatus comes with a rechargeable battery for mobility, boasts a user-friendly interface, and effectively gauges if patients require treatment or prescriptions for inhalers.

    Secure Your Global Breath Biopsy Testing Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    What Are the Main Segments of the Breath Biopsy Testing Market, and How Are They Evolving?

    The breath biopsy testingmarket covered in this report is segmented –

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Subsegments:

    1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

    2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

    3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

    4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

    Which Regions Are Driving Growth in the Breath Biopsy Testing Market?

    North America was the largest region in the breath biopsy testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Breath Biopsy Testing Market Defined Across Different Regions?

    Breath biopsy testing is a non-invasive diagnostic method that analyzes the chemical compounds in a person’s breath to detect and diagnose diseases. This testing is based on the principle that certain diseases, metabolic conditions, and physiological states produce unique chemical markers or volatile organic compounds (VOCs) that can be detected in the exhaled breath.

    Browse Through More Similar Reports By The Business Research Company:

    Smart Biopsy Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Non-invasive Prenatal Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Pharma Microbiology Testing Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharma-microbiology-testing-kits-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033

    Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033

    The Business Research Company’s Year-End Sale! Get up to 30% off on comprehensive market research reports—limited time only!

    At What Rate is the Breath Biopsy Testing Market Predicted to Expand Between 2024 and 2033?

    • The breath biopsy testing market size has grown strongly in recent years. It will grow from $2.96 billion in 2023 to $3.18 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%.

    • The breath biopsy testing market size is expected to see strong growth in the next few years. It will grow to $4.26 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%.

    Get A Free Sample On The Global Breath Biopsy Testing Market Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

    What Factors Are Encouraging Growth in the breath biopsy testing Market?

    • The rising prevalence of respiratory diseases is expected to propel the growth of the breath biopsy testing market going forward._x000D_

    • Respiratory diseases refer to medical conditions that impact on the lungs and airways, hindering a person’s ability to breathe efficiently._x000D_

    • The prevalence of respiratory diseases is due to increasing environmental pollution, higher rates of smoking, and the growing prevalence of chronic conditions such as asthma and chronic obstructive pulmonary disease (COPD)._x000D_

    Which Segments Are Crucial in the Breath Biopsy Testing Market?

    1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

    2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

    3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

    Purchase The Global Breath Biopsy Testing Market Report Directly And Get A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

    Which Market Leaders Are Behind the Growth of the Breath Biopsy Testing Market?

    Leading companies driving the global breath biopsy testing market include:

    • Drägerwerk AG & Co. KGaA_x000D_

    • Intoximeters Inc._x000D_

    • Owlstone Medical Ltd._x000D_

    • SKC Inc_x000D_

    • Lifeloc Technologies Inc._x000D_

    What Trends Are Driving Change in the #At What Rate is the Breath Biopsy Testing Market Predicted to Expand Between 2024 and 2033?# Market?

    • Major companies operating in the breath biopsy testing market are focused on developing innovative products, such as breath analyzers, to detect asthma._x000D_

    • Breath analyzers are diagnostic devices that detect and measure specific compounds in a person’s breath to identify medical conditions or assess health status._x000D_

    _x000D_

    Which Geographic Locations Are Critical to the Growth of the Breath Biopsy Testing Market?

    North America was the largest region in the breath biopsy testing market in 2023

    The Table Of Content For The Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Include

    1. Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Executive Summary

    2. Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Segments

    3. Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Size And Template Market Growth Rate

    4. Key Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Trends

    5. Major Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market

    26. Top Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Companies

    27. Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market Opportunities And Strategies

    28. Evaluating the Breath Biopsy Testing Market’s Growth Prospects from 2024 to 2033 Market, Conclusions And Recommendations

    29. Appendix

    Browse Through More Similar Reports By The Business Research Company:

    Liquid Biopsy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Global Biopsy Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Liquid Biopsy For Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: